title: Tandem high-dose chemotherapy and auto-SCT for malignant brain tumors in children under 3 years of age.
abstract: In an effort to improve survival and reduce late adverse effects of radiation therapy (RT), 25 children <3 years of age with malignant brain tumors received tandem high-dose chemotherapy (HDCT) and auto-SCT following six cycles of induction chemotherapy. RT was either not given or deferred until 3 years of age if the patient was in CR after tandem HDCT/auto-SCT. Tumors relapsed or progressed in nine patients (five during induction treatment), and two of these patients survived after receiving salvage treatment, including RT. Two patients died due to toxicities during tandem HDCT/auto-SCT. A total of 16 patients survived to a median follow-up period of 52 months (range 18-96) from the time of diagnosis. Four of these patients did not receive RT, two received local RT (L-RT), three received craniospinal RT (CSRT), and seven received both L-RT and CSRT. The 5-year OS and EFS rates were 67.8±9.4% and 55.5±10.0%, respectively. Neuroendocrine and neurocognitive functions evaluated 3 years after tandem HDCT/auto-SCT were acceptable. Our results indicate that tandem HDCT/auto-SCT may improve survival in young children with malignant brain tumors with an acceptable level of risk of long-term toxicity.
authors: Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
authors: K W
authors: KW
authors: Sung
authors: D H
authors: DH
authors: Lim
authors: S H
authors: SH
authors: Lee
authors: K H
authors: KH
authors: Yoo
authors: H H
authors: HH
authors: Koo
authors: J H
authors: JH
authors: Kim
authors: Y-L
authors: YL
authors: Suh
authors: Y S
authors: YS
authors: Joung
authors: H J
authors: HJ
authors: Shin
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D064592:Autografts; D001932:Brain Neoplasms / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D002675:Child, Preschool; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D033581:Stem Cell Transplantation; D015996:Survival Rate